A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- pharmaand GmbH
- Target Recruit Count
- 136
- Registration Number
- NCT01482715
- Locations
- 🇪🇸
Hospital Vall d'Hebron, Barcelona, Spain
🇮🇱Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
🇬🇧University College London Cancer Institute, London, United Kingdom
A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens
- First Posted Date
- 2009-11-06
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- pharmaand GmbH
- Target Recruit Count
- 85
- Registration Number
- NCT01009190
- Locations
- 🇬🇧
Churchill Hospital, Oxford, Oxfordshire, United Kingdom
🇬🇧Royal Marsden Hospital, Sutton, Surrey, United Kingdom
🇬🇧Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath